31st Dec 2019, the company and its subsidiaries recognized share of income, by using equity method, of Baht 0.45 million and 1.52 million in consolidated income statements or decreased by 30.8 percent in
% from 1Q2019. In 1Q2020, the Company recorded share of profit from investment in Joint Ventures, Thai Ethoxylates Company Limited (TEX) and GGC KTIS Bio Industrial Company Limited (GKBI), at THB 62
profit 53 53 (0) -1% Gross profit margin 13.8% 11.9% Other income 0 4 (4) -97% Selling & Admin expenses 30 26 4 16% 7.9% 5.9% Finance costs 13 12 1 7% Share of loss from associate 0 - Income tax expense (0
quarter ended June 30, 2020, the Group had net loss attributable to equity holders of the Company amounting to Baht 123.6 million which increased by 34.2% from the same period of previous year. Total
) (26.14) (9.36) 35.81% (19.58%) (21.51%) Tax income (expenses) (0.87) (3.16) (2.29) 72.47% (1.02%) (2.60%) Profit (loss) for the period (51.51) (53.95) 2.44 4.52% (60.12%) (44.39%) Basis earning per share
%) Basis earning per share-Owners of the company (0.04 ) (0.03 ) (0.062 ) (76.62%) - - Other comprehensive income Actuarial gain (Loss) Employee benefit plans Total Other Comprehensive income (0.30 ) - (0.30
(25.08) (37.91) (12.83) 33.84 (21.36) (23.73) Tax income (expenses) (0.87) (3.16) (2.29) 72.47 (0.74) (1.98) Profit (loss) for the period (74.18) (84.18) 10.00 11.88 (63.19) (52.68) Basis earning per share
ended 30th Sept 2019, the company and its subsidiaries recognized share of income, by using equity method, of Baht 0.55 million and 1.07 million in consolidated income statements respectively 1.7 Earning
. Shareholders' Equity As of September 30, 2019, the Company and its subsidiaries had total shareholder equity of 438.5 MB which increased from December 31, 2018 in amount of 47. 2 MB due to the Dividend payment
was 94.8 baht per share, increased from that of 91.3 baht per share as of February 28, 2023. Debt to Equity ratio as of November 30, 2023 was at 2.9 times decreased from 3.1 times as of February 28